ASX - Delayed Quote AUD

EVE Health Group Limited (EVE.AX)

Compare
0.0010
0.0000
(0.00%)
At close: March 31 at 10:02:23 AM GMT+11
Loading Chart for EVE.AX
  • Previous Close 0.0010
  • Open 0.0010
  • Bid --
  • Ask 0.0010 x --
  • Day's Range 0.0010 - 0.0010
  • 52 Week Range 0.0010 - 0.0010
  • Volume 323
  • Avg. Volume 51,865
  • Market Cap (intraday) 5.274M
  • Beta (5Y Monthly) 0.81
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date Feb 28, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

EVE Health Group Limited, together with its subsidiaries, engages in the retail and distribution of health and wellness products. The company offers organic raw honey and raw honey probiotic concentrates; and contract manufacturing services. It also sells its products through online store. The company was formerly known as EVE Investments Limited. EVE Health Group Limited was incorporated in 2003 and is based in Subiaco, Australia.

www.evehealthgroup.com.au

--

Full Time Employees

June 30

Fiscal Year Ends

Recent News: EVE.AX

View More

Performance Overview: EVE.AX

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

EVE.AX
0.00%
S&P/ASX 200 [XJO] (^AXJO)
6.02%

1-Year Return

EVE.AX
0.00%
S&P/ASX 200 [XJO] (^AXJO)
1.36%

3-Year Return

EVE.AX
39.98%
S&P/ASX 200 [XJO] (^AXJO)
2.05%

5-Year Return

EVE.AX
73.33%
S&P/ASX 200 [XJO] (^AXJO)
51.31%

Compare To: EVE.AX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: EVE.AX

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    5.27M

  • Enterprise Value

    5.04M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.63

  • Price/Book (mrq)

    12.65

  • Enterprise Value/Revenue

    2.52

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -87.74%

  • Return on Assets (ttm)

    -38.07%

  • Return on Equity (ttm)

    -105.17%

  • Revenue (ttm)

    2M

  • Net Income Avi to Common (ttm)

    -1.36M

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    384.92k

  • Total Debt/Equity (mrq)

    36.37%

  • Levered Free Cash Flow (ttm)

    1.34M

Research Analysis: EVE.AX

View More

Company Insights: EVE.AX

Research Reports: EVE.AX

View More

People Also Watch